FCCP
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 1mg | ¥140.00 | 现货 | |
| 5mg | ¥330.00 | 现货 | |
| 10mg | ¥500.00 | 现货 | |
| 25mg | ¥1115.00 | 现货 | |
| 50mg | ¥1818.00 | 现货 | |
| 100mg | ¥3080.00 | 现货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
The mitochondrial uncoupler FCCP (carbonyl cyanide p-trifluoro methoxyphenylhydrazone) functions as a lipophilic cationic proton translocator that freely carries dissociable protons across membranes and dissipates the proton gradient. This process removes the proton gradient required to drive ATP synthesis. IC50 value is 0.51 µM with treatment of T47D cells against FCCP. [1]
FCCP is a potent uncoupler of oxidative phosphorylation in mitochondria that disrupts ATP synthesis by transporting protons across cell membranes.
In vitro, FCCP increases the rate of cellular O2 consumption. In PC-3 and DU-145 prostate cancer cells, the compound could significantly decrease hypoxic as well as normoxic HIF-1 transcriptional activity which was in part mediated by down-regulation of the oxygen labile HIF-1α and HIF-2α protein levels. During hypoxic as well as normoxic, it decreases the expression of HIF target genes, VEGF and VEGF receptor-2. [2]
In vivo, FCCP reduces mitochondrial membrane potential and ATP production in 8-cell mouse embryos. Also, the number of inner cell mass cells decrease within blastocysts with unchanged blastocyst development. This perturbed embryonic mitochondrial function is concomitant with reduced birth weight in female offspring following embryo transfer, which persists until weaning. Although FCCP-treated males also exhibits reduced glucose tolerance as female, their insulin sensitivity and adiposity gain between 4 and 14 weeks is unchanged. Reducing mitochondrial function and, thus, decreasing ATP output in the precompacting embryo can influence offspring phenotype. [3]
References:
[1]. Du L, Mahdi F, Jekabsons MB, et al. Mammea E/BB, an isoprenylated dihydroxycoumarin protonophore that potently uncouplesmitochondrial electron transport, disrupts hypoxic signaling in tumor cells. J Nat Prod. 2010 Nov 29; 73 (11):1868-72.
[2] Thomas R, Kim MH. Targeting the hypoxia inducible factor pathway with mitochondrial uncouplers. Mol Cell Biochem. 2007 Feb; 296 (1-2):35-44.
[3] Zander-Fox DL, Fullston T2, McPherson NO2, et al. Reduction of Mitochondrial Function by FCCP During Mouse Cleavage Stage Embryo Culture Reduces Birth Weight and Impairs the Metabolic Health of Offspring. Biol Reprod. 2015 May; 92 (5):124.
产品性质
| 物理外观 | A crystalline solid |
| CAS号 | 370-86-5 |
| 分子式 | C10H5F3N4O |
| 分子量 | 254.17 |
| 化学名称 | (4-(trifluoromethoxy)phenyl)carbonohydrazonoyl dicyanide |
| 溶解度 | insoluble in H2O; ≥25 mg/mL in EtOH with ultrasonic; ≥56.6 mg/mL in DMSO with ultrasonic |
| SMILES | N#CC(C#N)=NNc(cc1)ccc1OC(F)(F)F |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | FCCP 是线粒体氧化磷酸化(OXPHOS)的解耦剂。FCCP 可诱导 PINK1 活化,导致 Parkin Ser65 磷酸化。 |



沪公网安备 31011002003500